Minimal residual disease (MRD)

DIAGNOSTIC_TEST2 trials

Sponsors

Helsinki University Central Hospital, Academisch Medisch Centrum

Conditions

Colorectal Cancerbraintumors

Unknown Phase

' Biomarkers for minimal residual disease in neuro-oncology ': MIRDINO study

Academisch Medisch Centrumbraintumors

Target: 400Updated: 2024-02-28

Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer

RecruitingNCT04842006

Helsinki University Central HospitalColorectal Cancer

Start: 2021-12-20End: 2031-12-31Target: 93Updated: 2023-03-06